Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. Gentuximab

   Changchun GeneScience Pharmaceutical Co.,

   Advanced Gastric or Gastroesophageal Junction Cancer

   phase 2 · small molecule · completed

   1 trial →

2. Giapreza 2.5 mg/ml concentrate for solution for infusion

   Disc Medicine

   Liver cancer (primary or secondary)

   phase 2 · small molecule · active

   1 trial →

3. Gilteritinib

   Astellas Pharma Inc

   Non-Small-Cell Lung Cancer

   phase 2 · small molecule · terminated

   1 trial →

4. Gimistotug

   BEONE MEDICINES AUS PTY LTD

   Non-Small Cell Lung Cancer

   phase 2 · small molecule · completed

   1 trial →

5. Giredestrant

   Hoffmann-La Roche

   Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer

   phase 2 · small molecule · active

   1 trial →

6. Giredestrant

   Hoffmann-La Roche

   Early Breast Cancer

   phase 2 · small molecule · completed

   1 trial →

7. Glasdegib

   Jazz Pharmaceuticals Ireland Limited

   Acute Myelogenous Leukemia (AML) Due to Therapy

   phase 2 · small molecule · active

   1 trial →

8. Gliolan 30 mg/ml powder for oral solution.

   Photonamic GmbH & Co. KG

   Colorectal Carcinoma

   phase 2 · small molecule · active

   1 trial →

9. Glofitamab

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Relapsed or Refractory Aggressive B-cell Lymphoma

   phase 2 · small molecule · active

   1 trial →

10. Glofitamab for previously untreated aggressive B-cell lymphoma

    The George Institute

    previously untreated aggressive B-cell lymphoma

    phase 2 · small molecule · active

    1 trial →

11. GnP in combination with Ivonescimab and SBRT

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatic Cancer

    phase 2 · other · active

    1 trial →

12. Green tea

    United Therapeutics Europe Ltd

    Lung Cancer Prevention

    phase 2 · other · completed

    1 trial →

13. Group A (FIT): Avapritinib + IA regimen

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia With T(8;21)(Q22;Q22)

    phase 2 · small molecule · active

    1 trial →

14. Group A：Patients with PR or ctDNA positivity after salvage treatment

    The First People's Hospital of Lianyungang

    Diffuse Large B-cell Lymphoma(DLBCL)

    phase 2 · small molecule · active

    1 trial →

15. HAIC + Tislelizumab +lenvatinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma (HCC)

    phase 2 · other · active

    1 trial →

16. HCD122

    Novartis Pharmaceuticals

    Non-Hodgkin's Lymphoma

    phase 2 · small molecule · completed

    1 trial →

17. HEC169096

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Solid Tumor

    phase 2 · small molecule · active

    1 trial →

18. HEM-iSMART - Sub B

    AXIM BIOTECHNOLOGIES, INC.

    Acute Lymphoblastic Leukemia, in Relapse Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Refractory

    phase 2 · small molecule · active

    1 trial →

19. HEM-iSMART sub C

    AXIM BIOTECHNOLOGIES, INC.

    Acute Lymphoblastic Leukemia, in Relapse Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Refractory

    phase 2 · small molecule · active

    1 trial →

20. HER3-DXd

    Daiichi Sankyo

    Advanced Solid Tumor

    phase 2 · small molecule · active

    1 trial →

21. HKI-272

    PUMA BIOTECHNOLOGY, INC.

    Advanced Breast Cancer

    phase 2 · small molecule · completed

    2 trials →

22. HKI-272

    PUMA BIOTECHNOLOGY, INC.

    Carcinoma, Non-Small-Cell Lung

    phase 2 · small molecule · completed

    1 trial →

23. HKI-272

    PUMA BIOTECHNOLOGY, INC.

    Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

24. HO155

    Wuhan Createrna Science and Technology Co., Ltd

    Acute myeloid leukemia, Myelodysplastic syndrome

    phase 2 · small molecule · active

    1 trial →

25. HO159

    Wuhan Createrna Science and Technology Co., Ltd

    Patients with relapsed CLL, Chronic lymphocytic leukemia

    phase 2 · small molecule · active

    1 trial →

26. HO161

    Disc Medicine

    relapsed/refractory Non-Hodgkin Lymphoma

    phase 2 · small molecule · active

    1 trial →

27. HRS-4642+AG+Nimotuzumab

    Zhejiang University

    Borderline Resectable Pancreatic Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

28. HRS-6213

    Jian Li

    Patients With Solid Tumors

    phase 2 · small molecule · active

    1 trial →

29. HRS-7058

    Shandong Suncadia Medicine Co.,

    Pancreatic Cancer

    phase 2 · small molecule · active

    1 trial →

30. Herzuma

    Vera Therapeutics

    HER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 Study

    phase 2 · small molecule · active

    1 trial →

31. High-Low Dose Radiotherapy

    Jian Li

    Nasopharyngeal Carcinoma (NPC)

    phase 2 · other · active

    1 trial →

32. Homoharringtonine

    Teva Pharma GmbH

    Myeloid Leukemia, Chronic

    phase 2 · small molecule · terminated

    1 trial →

33. Humanized CD7 CAR-T cells

    The First People's Hospital of Lianyungang

    T Lymphoblastic Leukemia/Lymphoma

    phase 2 · mab · active

    1 trial →

34. Hydrogen Peroxide

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 · small molecule · active

    1 trial →

35. Hyperbolic

    Talion

    non-small cell lung cancer (NSCLC)

    phase 2 · small molecule · active

    1 trial →

36. Hyperpolarized 13C-Pyruvate injection

    Hospital Authority, Hong Kong

    Gynecologic Cancer

    phase 2 · small molecule · active

    1 trial →

37. Hypofractionated radiation/chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-small Cell Lung Cancer

    phase 2 · other · completed

    1 trial →

38. I3Y-MC-JPCS

    Eli Lilly Co.

    Relapsed/Refractory Solid Tumors

    phase 2 · small molecule · active

    1 trial →

39. IAH0968

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Solid Tumor

    phase 2 · mab · active

    1 trial →

40. IAP0971

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Malignant Tumors

    phase 2 · small molecule · active

    1 trial →

41. IAP0971

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bladder Cancer

    phase 2 · small molecule · active

    1 trial →

42. IB 2018-04

    The George Institute

    Adult patients with locally advanced/unresectable and/or metastatic soft-tissue leiomyosarcomas.

    phase 2 · small molecule · active

    1 trial →

43. IB 2019-01

    The George Institute

    Adult participants with metastatic (advanced) solid tumors.

    phase 2 · small molecule · active

    1 trial →

44. IB 2019-03

    The George Institute

    Adult participants with advanced unresectable or metastatic soft-tissue sarcoma.

    phase 2 · small molecule · active

    1 trial →

45. IB 2019-04

    The George Institute

    Adult participants with metastatic or unresectable locally advanced solid tumors.

    phase 2 · small molecule · active

    1 trial →

46. IB 2019-07

    The George Institute

    Patients with locally advanced or metastasic Non-Small Cell Lung Carcinoma.

    phase 2 · small molecule · active

    1 trial →

47. IB 2020-02

    The George Institute

    Advanced /metastatic sarcomas: undifferentiated pleomorphic sarcoma, osteosarcoma and Ewing sarcoma.

    phase 2 · small molecule · active

    1 trial →

48. IB 2020-05

    The George Institute

    Adult patients with locally advanced/unresectable and/or metastatic soft-tissue sarcomas.

    phase 2 · small molecule · active

    1 trial →

Frequently asked questions